Skip to main content

1 Result(s)

within Biomedicine Remove this filter Biomedicine, general Remove this filter Yoshimasa Shiraishi Remove this filter

and
Your search also matched 1 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you. results, e.g.

Association of immune-related adverse events with durvalumab efficacy after chemoradiotherapy in patients with unresectable Stage III non-small cell lung cancer

Include preview-only content

  1. Article

    Open Access

    Phase II study of carboplatin/nab-paclitaxel/atezolizumab combination therapy for advanced nonsquamous non–small cell lung cancer patients with impaired renal function: RESTART trial

     First-line treatment of nonsquamous non–small cell lung cancer (NSCLC) has undergone a paradigm shift to platinum combination therapy together with immune checkpoint inhibitors (ICIs). However, phase III stud...

    Yoshimasa Shiraishi, Junji Kishimoto, Takayuki Shimose, Yukihiro Toi… in BMC Cancer (2022)

    Download PDF (887 KB) View Article